ARCHIVES

Cyclamate Committee Finds No Proof Of Carcinogenicity

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

ODAC Calls For Tougher Standards For Accelerated Approval In Oncology

February 11, 2011

In Brief: Durant To Retire From ASCO In A Year; Led Society Through Management Change

July 24, 1998

1978, ’79 budget Projections By Research Programs

November 25, 1977

NCI advisors approve $50 million pilot for Human Cancer Genome Project; NHLBI Director Collins calls it a “unique, historic opportunity.”

November 18, 2005

NCI’s SBIR Paylines Nears Regular Grants

September 20, 1985